Related Experiment Video
Updated: Mar 13, 2026

06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
5.6K
Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput
Shardul Paricharak1,2, Oscar Méndez-Lucio1,3, Aakash Chavan Ravindranath1
1Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, United Kingdom.
Briefings in Bioinformatics
|October 30, 2016
Summary
Data-driven approaches enhance high-throughput screening (HTS) by improving compound selection and prioritization. Novel activity modeling techniques boost hit rates and provide new insights into drug discovery.
Area of Science:
- Drug Discovery and Development
- Computational Chemistry
- Pharmacology
Background:
- High-throughput screening (HTS) is crucial for identifying drug candidates from chemical libraries.
- Data-driven strategies are increasingly employed to optimize HTS campaigns.
- Advancements in bioactivity-based similarity metrics have significantly impacted activity modeling.
Purpose of the Study:
- To provide an overview of data-driven approaches in HTS.
- To discuss novel activity modeling techniques and screening paradigms.
- To highlight the significance of these advancements in pharmaceutical research.
Main Methods:
- Review of recent developments in data-driven approaches for HTS.
- Elaboration on new activity modeling techniques.
- Exploration of innovative screening paradigms.
Main Results:
- Improved hit rates in iterative screening strategies.
- Enhanced compound prioritization through activity modeling.
- Novel insights into compound mode of action.
Conclusions:
- Data-driven methods, particularly advanced activity modeling, are transforming HTS.
- These approaches increase efficiency and effectiveness in identifying potential drug candidates.
- Continued exploration of these techniques promises further breakthroughs in drug discovery.
Related Concept Videos
Drug Discovery: Overview
12.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.6K
Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K

